- Home
- VYNE vs PIII Comparison
VYNE vs PIII Comparison
Compare VYNE & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VYNE | PIII |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 13.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | VYNE | PIII |
|---|---|---|
| Price | $0.59 | $3.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 14.9M | 10.3K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $524,000.00 | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.67 | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.29 | N/A |
| 52 Week Low | $0.28 | $3.50 |
| 52 Week High | $4.30 | $14.50 |
Technical Indicators
Market Signals| Indicator | VYNE | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 71.15 | 20.83 |
| Support Level | $0.56 | $3.51 |
| Resistance Level | $0.75 | $3.85 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 57.48 | 5.18 |
Price Performance
Historical ComparisonAbout VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.